Information Provided By:
Fly News Breaks for February 9, 2017
MDSO
Feb 9, 2017 | 13:08 EDT
JPMorgan analyst Sterling Auty says Medidata Solutions, in his opinion, reported the best quarter thus far in the earnings season. Bookings finished strong in 2016 and momentum is building for 2017, Auty tells investors in a post-earnings research note. He believes investors "should be taking a hard look" at the stock following the quarter and keeps an Overweight rating on the name with a $60 price target.
News For MDSO From the Last 2 Days
There are no results for your query MDSO
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.